144 related articles for article (PubMed ID: 10485624)
1. Management consideration in nonpulmonary visceral metastatic seminoma of testis.
Park DS; Prow DM; Amato RJ; Logothetis CJ
J Korean Med Sci; 1999 Aug; 14(4):431-7. PubMed ID: 10485624
[TBL] [Abstract][Full Text] [Related]
2. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.
Gholam D; Fizazi K; Terrier-Lacombe MJ; Jan P; Culine S; Theodore C
Cancer; 2003 Aug; 98(4):745-52. PubMed ID: 12910518
[TBL] [Abstract][Full Text] [Related]
3. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
4. [Late relapse of stage I testicular seminoma after 11 years: successful treatment with chemotherapy alone].
Detti B; Cipressi S; Di Cataldo V; Biti G
Actas Urol Esp; 2010 Jan; 34(1):118-9. PubMed ID: 20223144
[No Abstract] [Full Text] [Related]
5. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
6. Two cases of retroperitoneal metastasis from a completely regressed burned-out testicular cancer.
Gurioli A; Oderda M; Vigna D; Peraldo F; Giona S; Soria F; Cassenti A; Pacchioni D; Gontero P
Urologia; 2013; 80(1):74-9. PubMed ID: 23504866
[TBL] [Abstract][Full Text] [Related]
7. Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
Al-Hader AA; Jain A; Al-Nasrallah N; Einhorn LH
Am J Clin Oncol; 2015 Aug; 38(4):364-6. PubMed ID: 23799289
[TBL] [Abstract][Full Text] [Related]
8. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
9. [A case of synchronous cervical lymph node metastases from testicular and thyroid cancers showing mixed response to chemotherapy].
Matsumoto H; Nakane H; Aoki A; Naito K; Imate Y; Ohkami K; Isoyama R
Hinyokika Kiyo; 2000 Jul; 46(7):505-8. PubMed ID: 10965461
[TBL] [Abstract][Full Text] [Related]
10. [Metastatic pure testicular seminoma of the skin].
Tazi H; Badraoui M; Qasmi S; Hassam B
Prog Urol; 2011 Jan; 21(1):76-8. PubMed ID: 21193150
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis of pure seminoma at post-chemotherapy retroperitoneal lymph node dissection.
Rice KR; Beck SD; Bihrle R; Cary KC; Einhorn LH; Foster RS
J Urol; 2014 Nov; 192(5):1397-402. PubMed ID: 24813309
[TBL] [Abstract][Full Text] [Related]
12. Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors.
Cheng E; Berthold DR; Moore MJ; Duran I
Acta Oncol; 2009; 48(3):475-7. PubMed ID: 18932096
[No Abstract] [Full Text] [Related]
13. [Experience of the treatment for clinical Stage-1 seminoma over a period of 10 years].
Zhang XQ; Liu ZW; Zhou FJ; Han H; Qin ZK; Ye YL; Li YH; Hou GL; Zhang ZL
Chin J Cancer; 2010 Jan; 29(1):98-101. PubMed ID: 20038319
[TBL] [Abstract][Full Text] [Related]
14. Postchemotherapy residual masses in advanced seminoma: current management and outcomes.
Quek ML; Simma-Chiang V; Stein JP; Pinski J; Quinn DI; Skinner DG
Expert Rev Anticancer Ther; 2005 Oct; 5(5):869-74. PubMed ID: 16221056
[TBL] [Abstract][Full Text] [Related]
15. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
Peterson M; Beck S; Bihrle R; Einhorn L; Foster R
BJU Int; 2009 Jul; 104(2):176-8. PubMed ID: 19493258
[TBL] [Abstract][Full Text] [Related]
16. Management of retroperitoneal recurrences. Seminoma and nonseminoma.
Donohue JP; Foster RS
Urol Clin North Am; 1994 Nov; 21(4):761-72. PubMed ID: 7974905
[TBL] [Abstract][Full Text] [Related]
17. Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer.
Onozawa M; Kawai K; Yamamoto T; Hinotsu S; Tsukamoto S; Hattori K; Miyanaga N; Shimazui T; Akaza H
Int J Urol; 2004 Jul; 11(7):535-41. PubMed ID: 15242364
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of advanced seminoma treated with Einhorn's regimen].
Kawano S; Sakoda R; Sakamoto S; Ogata J
Gan No Rinsho; 1985 Apr; 31(4):449-52. PubMed ID: 2409310
[TBL] [Abstract][Full Text] [Related]
19. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative irradiation: another option for the treatment of > or = 3 cm residual mass following chemotherapy for advanced testicular seminoma.
Ravi R; Vasanthan A
Urol Int; 1995; 55(3):137-40. PubMed ID: 8540156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
